286A Stock Overview

Offers hospital management support services in Japan. More details

286A fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	1/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings are forecast to grow 27.54% per year

Revenue grew by 8.7% over the past year

Risk Analysis

Shares are highly illiquid

Less than 3 years of financial data is available

Has a high level of debt

My Notes

Capture your thoughts, links and company narrative

EUCALIA Inc. Competitors

I'rom Group

TSE:2372

JP¥33.7b

FALCO HOLDINGS

TSE:4671

JP¥25.5b

Charm Care

TSE:6062

JP¥43.1b

Solasto

TSE:6197

JP¥43.7b

Price History & Performance

Summary of share price highs, lows and changes for EUCALIA
Historical stock prices
Current Share Price	JP¥930.00
52 Week High	JP¥981.00
52 Week Low	JP¥756.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.20%

Recent updates

Shareholder Returns

	286A	JP Healthcare	JP Market
7D	19.7%	0.6%	2.1%
1Y	n/a	-9.4%	15.6%

Return vs Industry: Insufficient data to determine how 286A performed against the JP Healthcare industry.

Return vs Market: Insufficient data to determine how 286A performed against the JP Market.

Price Volatility

Is 286A's price volatile compared to industry and market?
286A volatility
286A Average Weekly Movement	n/a
Healthcare Industry Average Movement	3.3%
Market Average Movement	3.5%
10% most volatile stocks in JP Market	7.2%
10% least volatile stocks in JP Market	1.8%

Stable Share Price: 286A's share price has been volatile over the past 3 months compared to the JP market.

Volatility Over Time: Insufficient data to determine 286A's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2005	769	Hideo Misawa	eucalia.jp

EUCALIA Inc. offers hospital management support services in Japan. The company provides various hospital management services, such as strategy planning, fundraising, joint purchasing, regional collaboration, human resource acquisition, and reconstruction support, as well as resolves on-site quantitative and qualitative issues; on-site consulting services for business improvement, personnel issues, and hospital relocation and reconstruction; and digital transformation consulting services. It also collects and analyzes electronic medical record data and other medical big data; operates senior housing facilities, diagnostic imaging centers, and remote diagnostic imaging; publishes I-Life, a senior life total support information magazine; and manufacture and sell contact lenses.

EUCALIA Inc. Fundamentals Summary

How do EUCALIA's earnings and revenue compare to its market cap?
286A fundamental statistics
Market cap	JP¥32.77b
Earnings (TTM)	JP¥1.05b
Revenue (TTM)	JP¥18.05b

31.2x

P/E Ratio

1.8x

P/S Ratio

Is 286A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
286A income statement (TTM)
Revenue	JP¥18.05b
Cost of Revenue	JP¥10.95b
Gross Profit	JP¥7.11b
Other Expenses	JP¥6.06b
Earnings	JP¥1.05b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	29.82
Gross Margin	39.36%
Net Profit Margin	5.82%
Debt/Equity Ratio	183.0%

How did 286A perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 10:48
End of Day Share Price	2024/12/30 00:00
Earnings	2023/12/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EUCALIA Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ryotaro Hayashi	Morgan Stanley

EUCALIA TSE:286A Stock Report